Research Article
Volume 10 Issue 9 - 2021
Application of Povidone-Iodine for Treatment of Chylothorax in Children
Kozlov Yuri Andreevich1-3*, Kovalkov KA4, Poloyan SS5, Baradieva P Zh1, Zvonkov DA3, Ochirov Ch B1, Cheremnov VS1 and Kapuller VM6*
1Regional Children’s Teaching Hospital, Irkutsk, Russia
2Irkutsk State Medical Academy of Postgraduate Education, Irkutsk, Russia
3Irkutsk State Medical University, Irkutsk, Russia
4MBHI Children’s City Teaching Hospital, Kemerovo, Russia
5Maternal and Child Health Center, Krasnoyarsk, Russia
6Assuta University Medical Center, Ben Gurion University, Ashdod, Israel
*Corresponding Author: Kozlov Yuri Andreevich, Chief Medical Officer of the Regional State Funded Healthcare Facility, Children’s City Teaching Hospital, Irkutsk, Professor of the Department of Pediatric Surgery at the State Budgetary Educational Institution of Higher Professional Education ISMU, Professor of the Department of the State Budgetary Educational Institution of Higher Professional Education Irkutsk State Medical Academy of Postgraduate Education, Russia.
Received: July 26, 2021; Published: August 16, 2021


Introduction: The aim of this study is to demonstrate the experience of non-surgical treatment of congenital and acquired chylothorax using povidone-iodine in children.

Research Materials and Methods: The study presents the results of treatment of 10 patients with chylothorax who underwent chemical pleurodesis using the povidone-iodine medication. The study covered a period from 2016 to 2020. The congenital nature of the disease was registered in 2 patients, the acquired nature of the disease was reported with 8 patients. The main surgical indication was the lack of effect on conservative therapy, including feeding cessation and the administration of the octreotide medication. The procedure consisted of intrapleural injection of 4% povidone-iodine solution into the pleural cavity with a calculated dose of 1 ml/kg and exposure dose of the solution for 4 hours.

Results: The interpleural povidone iodine procedure was effective in all patients. Complications of chemical pleurodesis were registered with 2 patients and were associated with pulmonary edema on the injection side. Lymph outflow stopped on the 4th day, at average. One failure due to malformation of the lungs incompatible with life was reported.

Conclusion: Intrapleural administration of povidone-iodine is an effective treatment for chylothorax in children.

Keywords: Chemical Pleurodesis; Chylothorax; Povidone Iodine


  1. Scottoni F., et al. “Pleurodesis with povidone-iodine for refractory chylothorax in newborns: Personal experience and literature review”. Journal of Pediatric Surgery10 (2015): 1722-1725.
  2. Christofe NM., et al. “Incidence and Treatment of Chylothorax in Children Undergoing Corrective Surgery for Congenital Heart Diseases”. Brazilian Journal of Cardiovascular Surgery 5 (2017): 390-393.
  3. Dorsi M., et al. “Prenatal factors associated with neonatal survival of infants with congenital chylothorax”. Journal of Perinatology1 (2018): 31-34.
  4. Concheiro-Guisan A., et al. “The Practicality of Feeding Defatted Human Milk in the Treatment of Congenital Chylothorax 14.9 (2019): 648-653.
  5. White MK., et al. “Neonatal Chylothoraces: A 10-Year Experience in a Tertiary Neonatal Referral Centre”. Case Reports in Pediatrics (2019): 3903598.
  6. Long WG., et al. “Chemical pleurodesis and somatostatin in treating spontaneous chylothorax in pediatric patients: a retrospective analysis and review of the literature”. Translational Pediatrics4 (2020): 551-560.
  7. Le Nué R., et al. “Surgical management of congenital chylothorax in children”. European Journal of Pediatric Surgery5 (2010): 307-311.
  8. Moreira-Pinto J., et al. “Octreotide in the treatment of neonatal postoperative chylothorax: report of three cases and literature review”. Pediatric Surgery International8 (2011): 805-809.
  9. Soto-Martinez M and Massie J. “Chylothorax: diagnosis and management in children”. Paediatric Respiratory Reviews4 (2009): 199-207.
  10. Azizkhan RG., et al. “Pleuroperitoneal shunts in the management of neonatal chylothorax”. Journal of Pediatric Surgery6 (1983): 842-850.
  11. Brissaud O., et al. “Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone-iodine (Betadine)”. Archives of Disease in Childhood - Fetal and Neonatal Edition6 (2003): F531-533.
  12. De Beer H., et al. “Chylothorax”. The Netherlands Journal of Medicine 56 (2000): 25-31.
  13. Kim JE., et al. “Successful pleurodesis with OK-432 in preterm infants with persistent pleural effusion”. Korean Journal of Pediatrics 55 (2012): 177-180.
  14. Cho H., et al. “Chemical pleurodesis using a Viscum album extract in infants with congenital chylothorax”. European Journal of Pediatrics 173 (2014): 823-826.
  15. Mitanchez D., et al. “Congenital chylothorax: what is the best strategy?” Archives of Disease in Childhood - Fetal and Neonatal Edition 91 (2006): F153-154.
  16. Roehr CC., et al. “Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review”. Intensive Care Medicine 5 (2006): 650-657.
  17. Büttiker V., et al. “Chylothorax in children: guidelines for diagnosis and management”. Chest 3 (1999): 682-687.
  18. Rimensberger PC., et al. “Treatment of a persistent postoperative chylothorax with somatostatin”. The Annals of Thoracic Surgery 66 (1998): 253-254.
  19. Das A and Shah PS. “Octreotide for the treatment of chylothorax in neonates”. Cochrane Database of Systematic Reviews 08 (2010): CD006388.
  20. Bellini C., et al. “Octreotide for congenital and acquired chylothorax in newborns: A systematic review”. Journal of Paediatrics and Child Health 54 (2018): 840-847.
  21. Azam MN., et al. “Bilateral spontaneous chylothorax in a newborn and response to octreotide therapy”. International Journal of Contemporary Pediatrics 4 (2017): 658-660.
  22. Church JT., et al. “Evidence-based management of chylothorax in infants”. Journal of Pediatric Surgery 52 (2017): 907-912.
  23. Çakır U., et al. “Report of a case of neonatal chylothorax that responded to long-term octreotide treatment, and review of the literature”. The Turkish Journal of Pediatrics 57 (2015): 195-197.
  24. Saito M., et al. “High Dose Octreotide for the Treatment of Chylothorax in Three Neonates”. Journal of Neonatal Biology 5 (2016): 218.
  25. Dehghan K. “Idiopathic Chylothorax in a Term Neonate and Successful Treatment with Octreotide and Medium Chain Triglyceride - Enriched Formula: A Case Report”. International Journal of Pediatrics 7 (2019): 9535-9540.
  26. Cleveland K., et al. “Massive chylothorax in small babies”. Journal of Pediatric Surgery3 (2009): 546-550.
  27. Beghetti M., et al. “Etiology and management of pediatric chylothorax”. The Journal of Pediatrics5 (2000): 653-658.
  28. Wolff AB., et al. “Treatment of refractory chylothorax with externalized pleuroperitoneal shunts in children”. The Annals of Thoracic Surgery3 (1999): 1053-1057.
  29. Mattei P. “Editor. Fundamentals of Pediatric Surgery”. New York: Springer (2011): 311.
  30. Razumovsky A Yu and Stepanov EA. “Chylothorax in childhood [Khilotoraks v detskom vozraste]. M.: GEOTAR-Media (2011).
  31. Nath DS., et al. “Thoracic duct ligation for persistent chylothorax after pediatric cardiothoracic surgery”. The Annals of Thoracic Surgery 1 (2009): 246-251.
  32. Pego-Fernandes PM., et al. “Video-assisted thoracoscopy as an option in the surgical treatment of chylothorax after cardiac surgery in children”. Journal Brasileiro de Pneumologia 1 (2011): 28-35.
  33. Echavarría A., et al. “Intracavitary treatment of malignant pleural effusion with iodine-povidone”. Revista médica de Panamá 1 (1991): 69-74.
  34. Guo Y., et al. “Iodopovidon is as effective as doxycycline in producing pleurodesis in rabbits”. Respirology1 (2010): 119.
  35. Cohan RH., et al. “Povidone-iodine sclerosis of pelvic lymphoceles: a prospective study”. Urologic Radiology 4 (1988): 203-206.
  36. Olivares-Torres CA., et al. “Iodopovidone pleurodesis for recurrent pleural effusions”. Chest2 (2002): 581-583.
  37. Agarwal R., et al. “Efficacy and safety of iodopovidone pleurodesis: a systematic review and meta-analysis”. Indian Journal of Medical Research 135 (2012): 297-304.
  38. Murki S., et al. “Congenital chylothorax--successful management with chemical pleurodesis”. Indian Journal of Pediatrics 3 (2010): 332-334.
  39. Resch B., et al. “Povidone-iodine pleurodesis for congenital chylothorax of the newborn”. Archives of Disease in Childhood - Fetal and Neonatal Edition 101 (2016): F87-88.
  40. Borcyk K., et al. “Successful management of extremely high-output refractory congenital chylothorax with chemical pleurodesis using 4% povidone-iodine and propranolol: a case report”. Clinical Case Reports 4 (2018): 702-708.
Citation: Kozlov Yuri Andreevich., et al. “Application of Povidone-Iodine for Treatment of Chylothorax in Children”. EC Paediatrics 10.9 (2021): 03-10.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

September Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the September issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before October 14, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.